DNMT3A and breast cancer: We showed that 6ZFs‐DNMT3A fusions designed against the promoter and enhancer of the SOX2 transcription factor in breast cancer were associated with a window of epigenetic and transcriptional memory in a mouse model of breast cancer.[59, 60] Liu et al.